1. Home
  2. JAGX vs PLRZ Comparison

JAGX vs PLRZ Comparison

Compare JAGX & PLRZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • PLRZ
  • Stock Information
  • Founded
  • JAGX 2013
  • PLRZ 2005
  • Country
  • JAGX United States
  • PLRZ Israel
  • Employees
  • JAGX N/A
  • PLRZ N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • PLRZ
  • Sector
  • JAGX Health Care
  • PLRZ
  • Exchange
  • JAGX Nasdaq
  • PLRZ NYSE
  • Market Cap
  • JAGX 3.4M
  • PLRZ 3.7M
  • IPO Year
  • JAGX N/A
  • PLRZ 2024
  • Fundamental
  • Price
  • JAGX $2.30
  • PLRZ $1.01
  • Analyst Decision
  • JAGX Strong Buy
  • PLRZ
  • Analyst Count
  • JAGX 1
  • PLRZ 0
  • Target Price
  • JAGX $60.00
  • PLRZ N/A
  • AVG Volume (30 Days)
  • JAGX 97.0K
  • PLRZ 6.5M
  • Earning Date
  • JAGX 08-12-2025
  • PLRZ 02-15-2025
  • Dividend Yield
  • JAGX N/A
  • PLRZ N/A
  • EPS Growth
  • JAGX N/A
  • PLRZ N/A
  • EPS
  • JAGX N/A
  • PLRZ N/A
  • Revenue
  • JAGX $11,552,000.00
  • PLRZ N/A
  • Revenue This Year
  • JAGX $22.41
  • PLRZ N/A
  • Revenue Next Year
  • JAGX $30.00
  • PLRZ N/A
  • P/E Ratio
  • JAGX N/A
  • PLRZ N/A
  • Revenue Growth
  • JAGX 13.93
  • PLRZ N/A
  • 52 Week Low
  • JAGX $2.27
  • PLRZ $0.55
  • 52 Week High
  • JAGX $110.75
  • PLRZ $1,200.00
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 28.65
  • PLRZ N/A
  • Support Level
  • JAGX $2.28
  • PLRZ N/A
  • Resistance Level
  • JAGX $2.79
  • PLRZ N/A
  • Average True Range (ATR)
  • JAGX 0.14
  • PLRZ 0.00
  • MACD
  • JAGX 0.09
  • PLRZ 0.00
  • Stochastic Oscillator
  • JAGX 3.92
  • PLRZ 0.00

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About PLRZ POLYRIZON LTD

Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.

Share on Social Networks: